HomeEstrogen Containing Oral Contraceptive Preparations EthinyleEstrogen Containing Oral Contraceptive Preparations Ethinyle + Suzetrigine

Does Estrogen Containing Oral Contraceptive Preparations Ethinyle Interact with Suzetrigine?

Estrogen Containing Oral Contraceptive Preparations Ethinyle and Suzetrigine have a moderate drug interaction according to U.S. FDA drug labeling data. Patients using hormonal contraceptives with progestins other than levonorgestrel and norethindrone should use additional nonhormonal contraceptive or alternative hormonal contraceptive during JOURNAVX use and for 28 days after discontinuation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Suzetrigine Class
Sodium Channel Blocker
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Estrogen Containing Oral Contraceptive Preparations Ethinyle and your doctor is considering prescribing Suzetrigine (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Estrogen Containing Oral Contraceptive Preparations Ethinyle(Twirla)+💊 Suzetrigine(Journavx)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Sodium Channel Blocker
Source
NLP:suzetrigine

What this means in plain English

Patients using hormonal contraceptives with progestins other than levonorgestrel and norethindrone should use additional nonhormonal contraceptive or alternative hormonal contraceptive during JOURNAVX use and for 28 days after discontinuation.

About Estrogen Containing Oral Contraceptive Preparations Ethinyle and Suzetrigine

Suzetrigine is a Sodium Channel Blocker. You may recognize them by the brand names Twirla and Journavx. Suzetrigine is taken by mouth.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Estrogen Containing Oral Contraceptive Preparations Ethinyle and Suzetrigine against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.